Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a promising candidate for the treatment of both somatic and psychiatric disorders. NIH.gov
CBD Can Kill Bacteria Responsible For Several Superbugs, Research Says
JESS HARDIMAN
Published 21:02, Wednesday 20 January 2021 GMT ladbible.com
New Study Shows Cannabis Reduces Inflammatory ‘Storms’ Caused By COVID-19
Lindsey Bartlett
Published Jan 21, 2021,01:17pm EST forbes.com
CBD Destroys Antibiotic-Resistant Bacteria Such as Gonorrhea, Study Finds
Snigdha Bansal
Published January 21, 2021, 2:59am vice.com
Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products
By: Stephen M. Hahn, M.D., Commissioner of Food and Drugs and Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner FDA.gov
Medically reviewed by Dominique Fontaine, BSN, RN, HNB-BC, HWNC — Written by Louise Morales-Brown on January 14, 2021 medicalnewstoday.com
CBD vs. CBN: Benefits and Differences
Medically reviewed by Eloise Theisen, RN, MSN, AGPCNP-BC — Written by Daniel Yetman on January 14, 2021 healthline.com
High dose CBD study finds stunning potential for treating Alzheimer’s
MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY
Cannabis compound inhibits SARS-CoV-2 replication in human lung cells
By Sally Robertson, B.Sc.
Copyright © 2020 Plain Brands LLC - All Rights Reserved.
Phone: (234) 208-6496 Email: plainbrands@gmail.com
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
By clicking below you confirm that you are at least 18 years of age and legally permitted to buy and consume hemp